Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
We contrast TRI with price indices, highlighting dividends, corporate actions, and reinvestment assumptions that shape different performance pictures.
24,487 articlesBoxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
When a Federal Reserve chair signals a preference for policy stability over boom-and-bust cycles, it can upend how in...
A major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...
Midyear 2026 brings a wide range of state local sales rates across the U.S. Learn how these taxes are set, who they a...
Nvidia still dominates AI hardware, but the stock's sparkle has cooled. This article breaks down the three big reason...
Wall Street watches a hypothetical shift as chair kevin warsh just signals a new, discipline-focused approach at the ...
Hot IPOs spark excitement, but do they indicate a market top? This guide compares today’s IPO activity to past bubble...
This article breaks down Alliant Energy's 2025 earnings outlook, capital plan, and dividend strategy. Learn what to w...
Teaching money early doesn’t have to be complicated. These four money lessons your kids can learn before kindergarten...
Stepan (SCL) investors are focused on 2025 earnings drivers, margins, and cash flow. This guide breaks down the key c...
Life360 faces a pivotal year in 2026. This guide breaks down what the Q1 results could reveal about growth, margins, ...
Investors chase the next big tech story, and quantum computing stocks are no exception. This guide explains what tend...